BioNanomatrix's previous investors, KT Venture Group, the corporate venturing unit of semiconductor equipment company KLA-Tencor, and non-profit research group Battelle Memorial Institute through its corporate venturing units Battelle Ventures and Innovation Valley Partners, reinvested in the $23.3m B round.
BioNanomatrix, a US-based provider of analysis of the human genome, has raised $23.3m in its series B round.
BioNanomatrix’s previous investors, KT Venture Group, the corporate venturing unit of semiconductor equipment company KLA-Tencor, and non-profit research group Battelle Memorial Institute through its corporate venturing units Battelle Ventures and Innovation Valley Partners, reinvested in the B round.
The round was led by venture capital firm Domain Associates and joined by family office Gund Investment.
In March 2008, Battelle Ventures,…
